Implantable pressure sensor that could improve glaucoma treatment advances through Purdue agreement

WEST LAFAYETTE, Ind., and MEDWAY, Mass. – Qura Inc., a digital health care startup, has signed a license agreement with Purdue Research Foundation and a development agreement with Helbling Technique to advance its wireless implantable pressure sensor technology.

The product promise is to improve medical and surgical management for glaucoma surgeons and their patients by providing 24/7 event detection and real time updates on disease progression.

The Helbling agreement includes the design, development and manufacture of Qura’s implantable ‘Q-Smart’ sensor and data analytics system designed to monitor glaucoma, a disease of the eye in which excess fluid buildup causes high intraocular pressure, leading to damage to the optic nerve that may result in vision loss and ultimately, blindness.

“Physicians need as much information as possible to ideally prescribe and treat patients, and one of the biggest challenges they face is knowing how a prescribed drug and treatment regimen has been working,” said Douglas Adams, co-founder and CEO of Qura. “The wireless implantable pressure sensor we have developed will provide real-time continuous actionable data that can improve the treatment and outcomes for the patient.

 “What makes this minimally invasive micro implant unique is that it will operate autonomously regardless of patient activity. The programmable device collects data based on the physician’s requirement and that data is transmitted to a handheld device or tablet. The physician will now have actionable data on which to base their treatment plans for the patient,” Adams said.

Purdue researchers in the Weldon School of Biomedical Engineering, including Qura co-founder Pedro Irazoqui, helped develop the sensor and monitoring technology that has been licensed to Qura through the Purdue Research Foundation Office of Technology Commercialization.

About Qura Inc.

Qura seeks to become a leader in the field of physiological monitoring for preclinical research and human health applications. We are developing new micro diagnostic tools that can transform pressure monitoring in biomedicine. Qura’s pressure monitoring system may help speed research that leads to innovative pharmaceuticals and medical devices for human applications.

About Purdue Office of Technology Commercialization

The Purdue Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university\&\#39\;s academic activities. The office is managed by the Purdue Research Foundation, which received the 2016 Innovation and Economic Prosperity Universities Award for Innovation from the Association of Public and Land-grant Universities. For more information on licensing a Purdue innovation, contact the Office of Technology Commercialization at innovation@prf.org. For more information about funding and investment opportunities in startups based on a Purdue innovation, contact the Purdue Foundry at foundry@prf.org.

Purdue Research Foundation contact: Cynthia Sequin, 765-588-3340, casequin@prf.org  

Source: Douglas Adams, doug@qura.biz